1. Home
  2. VYGR vs FRGE Comparison

VYGR vs FRGE Comparison

Compare VYGR & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • FRGE
  • Stock Information
  • Founded
  • VYGR 2013
  • FRGE 2014
  • Country
  • VYGR United States
  • FRGE United States
  • Employees
  • VYGR N/A
  • FRGE N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • FRGE Computer Software: Prepackaged Software
  • Sector
  • VYGR Health Care
  • FRGE Technology
  • Exchange
  • VYGR Nasdaq
  • FRGE Nasdaq
  • Market Cap
  • VYGR 231.9M
  • FRGE 262.8M
  • IPO Year
  • VYGR 2015
  • FRGE N/A
  • Fundamental
  • Price
  • VYGR $4.21
  • FRGE $16.49
  • Analyst Decision
  • VYGR Strong Buy
  • FRGE Buy
  • Analyst Count
  • VYGR 8
  • FRGE 5
  • Target Price
  • VYGR $16.71
  • FRGE $35.50
  • AVG Volume (30 Days)
  • VYGR 635.7K
  • FRGE 87.0K
  • Earning Date
  • VYGR 11-11-2025
  • FRGE 11-05-2025
  • Dividend Yield
  • VYGR N/A
  • FRGE N/A
  • EPS Growth
  • VYGR N/A
  • FRGE N/A
  • EPS
  • VYGR N/A
  • FRGE N/A
  • Revenue
  • VYGR $42,580,000.00
  • FRGE $90,840,000.00
  • Revenue This Year
  • VYGR N/A
  • FRGE $32.56
  • Revenue Next Year
  • VYGR $107.07
  • FRGE $21.75
  • P/E Ratio
  • VYGR N/A
  • FRGE N/A
  • Revenue Growth
  • VYGR N/A
  • FRGE 14.78
  • 52 Week Low
  • VYGR $2.65
  • FRGE $6.60
  • 52 Week High
  • VYGR $8.28
  • FRGE $24.90
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 62.64
  • FRGE 36.37
  • Support Level
  • VYGR $3.91
  • FRGE $16.80
  • Resistance Level
  • VYGR $4.51
  • FRGE $18.93
  • Average True Range (ATR)
  • VYGR 0.27
  • FRGE 1.02
  • MACD
  • VYGR 0.05
  • FRGE -0.21
  • Stochastic Oscillator
  • VYGR 74.79
  • FRGE 1.75

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About FRGE Forge Global Holdings Inc.

Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.

Share on Social Networks: